|LETTER TO EDITOR
|Year : 2017 | Volume
| Issue : 3 | Page : 135-136
Acute diffuse and total alopecia of the female scalp albeit on immunossupression
Karina Lopes Morais, Alessandra Anzai, Neusa Yuriko Sakai Valente, Ricardo Romiti
Department of Dermatology, Univesity of São Paulo Medical School, São Paulo, Brazil
|Date of Web Publication||21-Aug-2017|
Karina Lopes Morais
Av. Dr. Eneas de Carvalho Aguiar, 255, 3rd Floor, Cerqueira César, São Paulo, SP 05403-900
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Morais KL, Anzai A, Valente NY, Romiti R. Acute diffuse and total alopecia of the female scalp albeit on immunossupression. Int J Trichol 2017;9:135-6
|How to cite this URL:|
Morais KL, Anzai A, Valente NY, Romiti R. Acute diffuse and total alopecia of the female scalp albeit on immunossupression. Int J Trichol [serial online] 2017 [cited 2020 Sep 25];9:135-6. Available from: http://www.ijtrichology.com/text.asp?2017/9/3/135/213337
Alopecia areata (AA) is a common nonscarring alopecia whose etiology has been linked to genetic predisposition, environmental triggers, and autoimmunity. Diffuse presentation of AA is rare and seems to affect predominantly females, with a short course of acute diffuse hair loss of the scalp., We describe the case of a patient that presented diffuse AA after an infectious pneumonia, despite long-term use of oral cyclosporine, mycophenolate, and prednisone after kidney transplantation.
A 46-year-old Brazilian woman presented with acute scalp hair loss 1 month after a hospitalization due to severe sepsis for pneumonia. She denied personal or familial history of AA. Fourteen years before, she underwent kidney transplantation for hypertensive nephropathy, with the use of systemic immunosuppression including oral mycophenolate sodium, cyclosporine, and prednisone. At the time, dosages were 720, 100, and 5 mg daily, respectively.
Clinical examination showed severe and diffuse nonscarring alopecia of the scalp, some sparse thin hairs, and no involvement of eyebrows, eyelashes, and corporal hairs [Figure 1]. Trichoscopy revealed black dots, few exclamation mark hairs, and short regrowing hairs with no epidermal changes [Figure 1]. Biopsy of the parietal area revealed hair follicle miniaturization with increased vellus hairs and increased telogen hair count. Melanin deposition was present into follicular canal, follicular epithelium, and telogen terminal units [Figure 2].
|Figure 1: Initial presentation with diffuse nonscarring alopecia of the scalp (a). Improvement after 1 (b) and 5 months (c). Initial trichoscopy (×20) showing black dots, localized exclamation mark hair, and short regrowing hairs (d). Normal trichoscopy (×20) after 5 months of treatment (e)|
Click here to view
|Figure 2: Hair follicle miniaturization, increased vellus hairs, and melanin deposits into telogen terminal units (H and E, ×100)|
Click here to view
Treatment with topical minoxidil 5% and clobetasol was instituted, and progressive hair regrowth was observed [Figure 1].
The diffuse presentation of AA is rare and few articles were published so far., Diffuse AA has a noticeable female predominance and is clinically characterized by severe, rapidly progressive, and diffuse scalp hair shedding with remarkably favorable prognosis. Dystrophic and exclamation mark hairs and miniaturization are present. After dramatic presentation, almost all cases are followed by clinical remission and spontaneous hair growth regardless specific treatments. Some authors have termed this particular subtype of AA as “acute diffuse and total alopecia” that we believe to be the same entity.,, Acute symptoms onset and good improvement after few weeks of topical treatment in our patient reaffirm the classically described clinical course.
Histology of diffuse AA is indistinguishable from the other presentations,, but some authors observed higher incidence of perifollicular eosinophilic infiltration  or even prominent dermal and follicular pigment incontinence in this subtype. In our case, the typical feature of peribulbitis was absent, but the increase of vellus hairs and telogens and melanin deposits in follicular epithelium was consistent with AA as described by Peckman et al.
Few cases of diffuse AA have been described after infections  and immunomodulatory drugs. Most of the published cases had no triggers detected. Lew reported thirty diffuse AA cases, and only five had possible triggering factors including psychological trauma, pregnancy, weight loss, and systemic illness.
There is no clear explanation for the occurrence of AA despite long-term administration of immunosuppressive drugs. Few cases of AA in patients using cyclosporine , and mycophenolate  were reported. Some authors suggested that dosage could be insufficient to prevent T-cell activation in those patients. More studies are necessary to understand the pathogenesis of AA and its correlation with autoimmunity and immunosuppressive drugs.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010;62:177-88.
Sato-Kawamura M, Aiba S, Tagami H. Acute diffuse and total alopecia of the female scalp. A new subtype of diffuse alopecia areata that has a favorable prognosis. Dermatology 2002;205:367-73.
Lew BL, Shin MK, Sim WY. Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis. J Am Acad Dermatol 2009;60:85-93.
Bhardwaj EK, Trüeb RM. Acute diffuse and total alopecia of the female scalp associated with borrelia-infection. Int J Trichology 2015;7:26-8.
Peckham SJ, Sloan SB, Elston DM. Histologic features of alopecia areata other than peribulbar lymphocytic infiltrates. J Am Acad Dermatol 2011;65:615-20.
Dy LC, Whiting DA. Histopathology of alopecia areata, acute and chronic: Why is it important to the clinician? Dermatol Ther 2011;24:369-74.
Nadesalingam K, Goodfield M, Emery P. Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy. Oxf Med Case Reports 2016;2016:omw027.
Davies MG, Bowers PW. Alopecia areata arising in patients receiving cyclosporin immunosuppression. Br J Dermatol 1995;132:835-6.
Roger D, Charmes JP, Bonnetblanc JM. Alopecia areata occurring in a patient receiving systemic cyclosporin A. Acta Derm Venereol 1994;74:154.
Zuk DM, Koh A, Imes S, Shapiro AM, Senior PA. Three cases of alopecia following clinical islet transplantation. Am J Transplant 2011;11:163-8.
[Figure 1], [Figure 2]